Darwin Wealth Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
Darwin Wealth Management's AVNS Position: Q3 2026 in Review
Darwin Wealth Management sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 25 shares — an estimated $622 sold.
Darwin Wealth Management first reported a position in AVNS in Q1 2020 and held it in 9 quarters. The position peaked at $622 in Q2 2026. 4 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.
- Darwin Wealth Management reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
- Darwin Wealth Management sold 25 Avanos Medical shares in Q3 2026, an estimated $622.
- Darwin Wealth Management first reported a position in Avanos Medical in Q1 2020 and held it in 9 quarters.
- Darwin Wealth Management's Avanos Medical position peaked at $622 in Q2 2026.
- 4 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.
Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.